Showing results (621-630 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|March 7, 2006
Treatment of primary progressive freezing of gait with high doses of selegilineCarlos Zúñiga, Jacobo Lester, María Graciela Cersósimo, et al.Clinical Neuropharmacology|March 7, 2006
Immunotherapy for Alzheimer's disease and other dementiasDelphine Boche, James A R Nicoll, Roy O WellerClinical Neuropharmacology|January 1, 1985
Effects of a new benzodiazepine derivative, ethyl loflazepate (CM6912), on the arousal level of normal humans assessed by the averaged photopalpebral reflexM Tanaka, Y Mizuki, H Isozaki, et al.Clinical Neuropharmacology|February 20, 2002
Pergolide in the treatment of patients with early and advanced Parkinson's diseaseUbaldo Bonuccelli, Anna Colzi, Paolo Del DottoClinical Neuropharmacology|February 20, 2002
Copolymer 1 (glatiramer acetate) in relapsing forms of multiple sclerosis: open multicenter study of alternate-day administrationShlomo Flechter, Edna Kott, Bettina Steiner-Birmanns, et al.Clinical Neuropharmacology|February 20, 2002
In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetineBeata Horvath, Zsolt Marton, Robert Halmosi, et al.Clinical Neuropharmacology|February 20, 2002
Epidural lipomatosis secondary to indinavir in an HIV-positive patientMaría Graciela Cersósimo, Beatriz Lasala, Silvia Folgar, et al.Clinical Neuropharmacology|February 20, 2002
Side effects of long-term treatment with fluoxetineNili Buchman, Rael D Strous, Yehuda BaruchClinical Neuropharmacology|December 9, 1998
MK-801-induced dystonia in cebus monkeysM Madsen, H LublinClinical Neuropharmacology|December 9, 1998
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's diseaseP J Blanchet, J Fang, M Gillespie, et al.Pageof 236